Learning Objective 1: Recognize the syndrome and laboratory features of Hashimoto's Encephalopathy

Learning Objective 2: Discuss proposed pathophysiologic mechanisms for Hashimoto's Encephalopathy

Learning Objective 3: Discuss treatment options including those for steroid resistant cases as well as prognosis

 

Session date: 
Tuesday, May 30, 2017 - 8:00am to 9:00am
Speaker Name: 
Angela Mark, MD
Location: 
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.